Tylenol maker’s stock dips after report says RFK Jr.’s HHS plans to link the drug to autism

Drug maker Kenvue, which makes Tylenol, saw its shares slump following a Wall Street Journal report that RFK Jr.’s health department plans to link the drug to autism.

The U.S. Department of Health and Human Services is planning to release a report that will reportedly link autism and acetaminophen use in pregnancy, according to The Wall Street Journal. The department has confirmed a report is in the works, but has not revealed its conclusions.